NT-proBNP predicts short-term cancer diagnosis
José Tuñón1,2,3,4, Álvaro Aceña1,2 , Ana Pello1,2 , Sergio Ramos-Cillán2, Juan Martínez-Milla1,2 , Óscar González-Lorenzo1,2 , Jesús Fuentes-Antras5, Nieves Tarín6 , Carmen Cristóbal7,8 , Luis M. Blanco-Colio3,4 , José Luis Martín-Ventura2,3,4 , Ana Huelmos9 , Carlos Gutiérrez-Landaluce7, Marta López-Castillo1,2 , Joaquín Alonso8,10 , Lorenzo López Bescós8 , Luis Alonso-Pulpón2,11, Jesús Egido2,3,12 , Ignacio Mahíllo-Fernández13, Óscar Lorenzo2,3,12
1 Department of Cardiology, IIS-Fundación Jiménez Díaz, Madrid, Spain
2 Autónoma University, Madrid, Spain
3 Laboratory of Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain
4CIBERCV, Madrid, Spain
5 Department of Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain
6 Department of Cardiology, Hospital Universitario de Móstoles, Madrid, Spain
7 Department of Cardiology, Hospital de Fuenlabrada, Madrid, Spain
8 Rey Juan Carlos University, Alcorcón, Madrid, Spain
9 Department of Cardiology, Hospital Universitario Fundación Alcorcón, Madrid, Spain10 Department of Cardiology, Hospital de Getafe, Madrid, Spain
11Department of Cardiology, Hospital Puerta de Hierro, Madrid, Spain
12 CIBERDEM, Madrid, Spain
13 Research Unit, IIS-Fundación Jiménez Díaz, Madrid, Spain